GL
ONCE

GLG LLC’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

GLG LLC’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16,800
Closed -$496K – 551
2016
Q1 		$496K Sell
16,800
-3,200
-16% -$101K 0.03% 437
2015
Q4 		$906K Buy
+20,000
New +$1.05M 0.05% 325
2015
Q3 		– Sell
-16,784
Closed -$1.01M – 646
2015
Q2 		$1.01M Buy
+16,784
New +$1.11M 0.02% 474

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

GLG LLC's ONCE Position: Q2 2016 in Review

GLG LLC sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2016, closing a stake of 16,800 shares — an estimated $496K sold.

GLG LLC first reported a position in ONCE in Q2 2015 and held it in 3 quarters. The position peaked at $1.01M in Q2 2015. 115 funds tracked by Wall St. Rank hold ONCE as of Q2 2016.

  • GLG LLC reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • GLG LLC sold 16,800 Spark Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $496K.
  • GLG LLC first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 3 quarters.
  • GLG LLC's Spark Therapeutics, Inc. Common Stock position peaked at $1.01M in Q2 2015.
  • 115 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2016.

Based on GLG LLC's 13F filing for Q2 2016, filed 16 Aug 2016.